Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Accounts Payables (2016 - 2025)

Hypha Labs filings provide 15 years of Accounts Payables readings, the most recent being $472551.0 for Q3 2025.

  • On a quarterly basis, Accounts Payables rose 447.26% to $472551.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $472551.0, a 447.26% increase, with the full-year FY2025 number at $472551.0, up 447.26% from a year prior.
  • Accounts Payables hit $472551.0 in Q3 2025 for Hypha Labs, up from $383256.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $571121.0 in Q4 2022 to a low of $86348.0 in Q3 2024.
  • Median Accounts Payables over the past 5 years was $329307.0 (2021), compared with a mean of $283993.5.
  • Biggest five-year swings in Accounts Payables: crashed 83.85% in 2023 and later skyrocketed 447.26% in 2025.
  • Hypha Labs' Accounts Payables stood at $368026.0 in 2021, then skyrocketed by 55.18% to $571121.0 in 2022, then plummeted by 83.85% to $92220.0 in 2023, then skyrocketed by 56.04% to $143897.0 in 2024, then soared by 228.4% to $472551.0 in 2025.
  • The last three reported values for Accounts Payables were $472551.0 (Q3 2025), $383256.0 (Q2 2025), and $330574.0 (Q1 2025) per Business Quant data.